1. Home
  2. JFIN vs STXS Comparison

JFIN vs STXS Comparison

Compare JFIN & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JFIN

Jiayin Group Inc.

HOLD

Current Price

$2.16

Market Cap

149.7M

Sector

Finance

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.26

Market Cap

164.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JFIN
STXS
Founded
2011
1990
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.7M
164.1M
IPO Year
2018
2004

Fundamental Metrics

Financial Performance
Metric
JFIN
STXS
Price
$2.16
$1.26
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
62.6K
1.2M
Earning Date
06-03-2026
05-12-2026
Dividend Yield
17.47%
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
N/A
$28.22
Revenue Next Year
N/A
$30.47
P/E Ratio
$1.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.12
$1.24
52 Week High
$14.70
$3.59

Technical Indicators

Market Signals
Indicator
JFIN
STXS
Relative Strength Index (RSI) 22.96 27.66
Support Level N/A N/A
Resistance Level $4.54 $1.97
Average True Range (ATR) 0.14 0.12
MACD 0.02 -0.02
Stochastic Oscillator 7.68 3.91

Price Performance

Historical Comparison
JFIN
STXS

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: